Boston Scientific Announces Results For Second Quarter 2016
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Wedbush Raises Price Target on Boston Scientific (BSX) to $25 Following 2Q
July 29, 2016 8:14 AM EDTWedbush reiterated a Neutral rating on Boston Scientific (NYSE: BSX), and raised the price target to $25.00 (from $23.00), following the company's 2Q earnings report. Total sales were $2.126 billion, and $80 million ahead of consensus, while adjusted EPS of $0.27 was in line.
Analyst Tao Levy... More
Boston Scientific (BSX) PT Raised to $28 at Needham & Company
July 28, 2016 2:38 PM EDTNeedham & Company analyst Mike Matson reiterated a Buy rating and bumped his price target on Boston Scientific (NYSE: BSX) to $28.00 (from $26.00) following doubled-digit organic growth in Q2.
Matson commented, "BSX beat consensus 2Q16 revenue and met consensus EPS. BSX's organic constant currency... More
Boston Scientific (BSX) PT Bumped to $26 at Evercore ISI
July 28, 2016 12:46 PM EDTEvercore ISI analyst Vijay Kumar reiterated a Buy rating and lifted his price target on Boston Scientific (NYSE: BSX) to $26.00 (from $25.50) following results this morning.
The firm maintained FY 2016 EPS of $1.11, FY 2017 EPS of $1.30 and raised FY 2018 EPS from $1.52 to $1.55.
Kumar commented, "Just when investors sighed a breath of relief after last Q when the long awaited new product momentum drove a... More
Boston Scientific (BSX) Reports In-Line Q2 EPS; Bumps FY16 Rev View
July 28, 2016 6:34 AM EDTBoston Scientific (NYSE: BSX) reported Q2 EPS of $0.27, in-line with the analyst estimate of $0.27. Revenue for the quarter came in at $2.13 billion versus the consensus estimate of $2.05 billion.
"Our strong performance is evidence of the success of our category leadership strategy," said Mike... More
